Abstract
Objective To re-evaluate the longitudinal progression of stroke-induced homonymous visual field defects using strictly automated perimetry (Zeiss Humphrey Systems), rigorous inclusion/exclusion criteria, and quantitative analyses.
Methods A retrospective chart review of stroke patients diagnosed with “homonymous hemianopia”, who underwent monocular Humphrey visual field (HVF) perimetry using the 24-2 SITA standard pattern from 2011-2019, was conducted at a large US academic medical center. Reliable tests (<20% fixation losses, false positives, and false negatives) were identified and analyzed with generalized estimating equations to extract temporal trends in perimetric mean deviation (PMD) and deficit area.
Results Of 532 patients with “homonymous hemianopia”, sequential, reliable HVFs were only available for 36 patients in the right eye, and 30 patients in the left eye, ranging from 7 days to 58 months post-stroke. Both PMD and deficit area improved early, within the first 3 months post-stroke; however, this was followed by a subsequent decline in performance >1 year post-stroke. Changes were similar between eyes.
Conclusion We discovered that a large portion of occipital stroke patients do not receive comprehensive ophthalmologic follow-up and, even then, only a fraction of HVFs performed are reliable enough for rigorous analysis. Nonetheless, reliable HVFs in such patients confirmed early visual improvement after stroke, consistent with prior reports. However, in contrast with prior, qualitative reports, there was no stability of the deficit beyond 6 months post-stroke; instead, gradual worsening erased the initial spontaneous improvement, especially >1 year post-stroke.
- Stroke
- homonymous hemianopia
- natural history
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by NIH grant R01 EY027314 (ELS, KRH, MRC, BAJ), NIH grants UL1 TR002001, T32 GM007356, TL1 TR002000 (ELS), a Research to Prevent Blindness/Lions Club International Foundation Low Vision Award (GKA), and an unrestricted grant to the Department of Ophthalmology at the University of Rochester from Research to Prevent Blindness.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Rochester Medical Center Research Subjects Review Board gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Elizabeth L. Saionz saionz.elizabeth{at}mayo.edu
Matthew R. Cavanaugh matthew_cavanaugh{at}urmc.rochester.edu
Brent A. Johnson brent_johnson{at}urmc.rochester.edu
Donald Harrington donald_harrington{at}urmc.rochester.edu
Geoffrey K. Aguirre aguirreg{at}upenn.edu
Krystel R. Huxlin khuxlin{at}ur.rochester.edu
Financial Disclosures Drs. Saionz, Cavanaugh, Johnson, Harrington, Aguirre and Huxlin have no disclosures pertinent to this work.
Study Funded by NIH grant R01 EY027314 (ELS, KRH, MRC, BAJ), NIH grants UL1 TR002001, T32 GM007356, TL1 TR002000 (ELS), a Research to Prevent Blindness/Lions Club International Foundation Low Vision Award (GKA), and an unrestricted grant to the Department of Ophthalmology at the University of Rochester from Research to Prevent Blindness.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
